I’ve been wanting to talk about this subject for a while now, but it’s so complex a topic…
Articles by Ines Martins, PhD
Anthera Pharmaceuticals announced that William Shanahan, MD, has been appointed its chief medical officer, with responsibilities that include advancing a potential treatment…
The Lupus Research Alliance welcomed the report, by Aurinia Pharmaceuticals, of positive top-line results in its Phase 2 clinical trial results of…
In a recent published article, the president and chief executive officer of Lupus Foundation of America (LFA) Sandra C. Raymond discussed…
Many studies have established that patients with autoimmune diseases such as rheumatoid arthritis (RA), multiple sclerosis (MS), Sjögren’s syndrome, and systemic lupus…
Improper clearing of dying cells and elevated levels of RNA and DNA in serum are connected to increased chronic inflammation in…
Results from two Phase 3 trials revealed that patients with systemic lupus erythematosus (SLE) can benefit from the recombinant human monoclonal…
Aurinia Pharmaceuticals recently announced positive top-line results from the voclosporin Phase 2b clinical trial AURA-LV (AURA) in patients with…
It started off as my dream place to live… an “if I could live anywhere” kind of place. We vacationed in the…
XTL Biopharmaceuticals has filed a new U.S. patent application to protect doses of hCDR1 lower than 0.5 mg per week…